Marco Roffi1, MD; Davide Capodanno2, MD, PhD; Stephan Windecker3, MD; Andreas Baumbach4,5, MD, PhD; Dariusz Dudek6,7, MD, PhD
1. Division of Cardiology, University Hospitals, Geneva, Switzerland; 2. Division of Cardiology, CAST, P.O. “G. Rodolico”, Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italy; 3. Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland; 4. Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, Barts Heart Centre, London, United Kingdom; 5. Yale University School of Medicine, New Haven, CT, USA; 6. Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland; 7. Maria Cecilia Hospital GVM, Cotignola, Ravenna, Italy
COVID-19 disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), has imposed an unprecedented burden on healthcare systems worldwide. While guidance on management of cardiovascular conditions in the setting of COVID-19 is being gathered, little is known about the effects of the pandemic on interventional cardiology practice . The first reports originating from highly affected areas describe a reduction in the number of patients presenting to the emergency department (ED) with acute coronary syndromes (ACS) [2,3]. In order to shed light on the impact of the COVID-19 pandemic on the management of patients encountered in routine interventional ...